e.g. Tata motors, Reliance MF, 500570

Aurobindo Pharma Ltd - Curateq Biologics Receives Marketing Approval For Trastuzumab Biosimilar Dazublys??? From European Commission

Download announcement < Back
04:54 PM
Intimation of receipt of marketing approval for trastuzumab biosimilar Dazublys from European Commission by Curateq Biologics s.r.o a wholly owned step down subsidiary of the Company.
View all announcements for Aurobindo Pharma Ltd Source: BSE India

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback